Article

FDA Challenges Stem Cell Companies As Patients Run Out Of Time

Americans seeking stem cell replacement therapy hope the process can heal them of myriad diseases, and a 2011 report by the Baker Institute estimated the industry could bring in $16 billion in revenue by 2020.

But the Food and Drug Administration has expressed concerns. The agency sued to stop treatments at a Regenerative Sciences clinic in Colorado and closed the lab of another company, Celltex Therapeutics, in Texas.

Read the full story: http://n.pr/12iZOhV

Source: NPR

Related Videos
ATS 2025
Bridgette J. Picou, LVN, ACLPN, The Well Project
John Barkett, MBA
1 expert in this video
Dr Gerard Criner
Emma Achola-Kothari, PhD
Dr Margrit Wiesendanger
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo